Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The General Objective of this study is to investigate the cost and efficacy of treating patients undergoing colorectal surgical resections with an opioid limited pain control regimen as part of an Enhanced Recovery After Surgery (ERAS) Protocol. This group will be compared to a traditional opioid based pain control regimen.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: OSF Healthcare System; University of Illinois College of Medicine at Peoria
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Bupivacaine; Fentanyl; Gabapentin; Hydrocodone; Hydromorphone; Ketamine; Ketorolac; Ketorolac Tromethamine; Lidocaine; Methadone; Morphine; Narcotics; Orphenadrine; Oxycodone; Tramadol

Criteria

Inclusion Criteria:

• Males or females above the age of 18

• Patients undergoing laparoscopic or robotic colorectal resections

Exclusion Criteria:

• History of constipation

• Pre-existing use of narcotics or opioids

• Pre-existing renal or hepatic failure

• Mental illness, mental retardation, or inability to participate in informed consent due to mental status

• Pre-existing dementia

• Allergy to any protocol medication

• Emergency operation

• Subjects who are incarcerated or wards of the state

• Minors

• Subjects with inflammatory bowel disease, active colitis, or pre-existing intra-abdominal inflammation. Diverticulitis without active infection/inflammation will not be excluded.